Source: Annual Congress 2003 - Pulmonary circulation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Valerio, P. Barcciale, G. Legari, S. Bellanova, G. Lupo (San Pietro Vernotico, Italy). Brtain natriuretic peptide in chronic obstructive pulmonary disease under stable state and respiratory failure. Eur Respir J 2003; 22: Suppl. 45, 1758

Member's Comments

No comment yet.

Related content which might interest you: The effect of diuretics on plasma brain natriuretic peptide level in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008 Fluid homeostasis in chronic obstructive lung disease Source: Eur Respir J 2003; 22: 33S-40S Year: 2003 Respiratory failure in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 26S Year: 2003 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting Year: 2010 Study over chronic obstructive pulmonary disease patients with hypercapnic respiratory failure Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 The role of amino-terminal pro-brain natriuretic peptide (NT-proBNP in clinical evaluation of patient with acute exacerbation chronic obstructive pulmonary disease Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Elevation of cardiac enzymes in COPD patients with respiratory failures Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Peculiarities of cardiac rhythm in stable chronic obstructive pulmonary disease Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Obstructive pulmonary disease with acute respiratory failure Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11 Year: 2001 The effects of elevated troponin I on long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Cardiac response to exercise in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009 Mechanisms of ECG changes in chronic obstructive pulmonary disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Long-term effects of non-invasive ventilation in chronic respiratory failure due to chronic obstructive lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 280s Year: 2002 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Association of phase angle and hypoxemia in ambulatory patients with chronic obstructive pulmonary disease and heart failure. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018